Accelmed Ventures, part of Accelmed investment house, aims to create successful medical device and digital health companies by using its deep expertise, extensive network and proven track record.
Accelmed Ventures positions itself as a leading HealthTech venture fund, investing globally while focusing on:
Medical Devices and Digital Health companies with exceptional leading teams
Innovative solutions addressing unmet needs in major chronic disease areas such as neurodegenerative, oncology, metabolic and cardiovascular diseases
Companies with a proven clinical concept and/or a proven business model
Accelmed Ventures, with its global presence, diverse team background, syndication capabilities with investors worldwide and strong partnerships all over the world with medical centers helps its portfolio companies to thrive.
We are more than just another fund!
Dr. Irit Yaniv, MD, MBA
Irit Yaniv is an experienced and accomplished senior executive in the Medtech industry. Since joining Accelmed, in 2012, she plays a significant role in leading Accelmed’s ventures portfolio companies, serving either as Chairperson or as an active board member. During these years, she advanced the international network, while expanding the reach of Accelmed companies towards relationship with strategic investors and financial syndication.
She was the co-founder of two of Accelmed’s portfolio companies in the field of metabolic disorders – e.g. Diabetes and Obesity.
Previously, she held operational positions with different medical device companies, including serving as CEO for Metacure and Impulse Dynamics.
She is heavily involved in the Israeli Eco-System, taking an active part in the BioMed, ICI and WHII conferences as well as 8400 project (cohort 2).
Dr. Yaniv holds an MD degree from the Ben-Gurion University and an MBA from the Recanati Business School at Tel Aviv University.
Amir Blatt brings a wide experience in the HealthTech field. He joined Accelmed in 2010 and led or played a pivotal role in the vast majority of its venture and private equity investments including deal structure, syndication and establishing business models. Mr. Blatt serves as a board member on a number of Accelmed companies in the US and Israel.
Prior to joining Accelmed, Mr. Blatt worked at Goren Capital Group, a boutique investment bank, advising investors and TA-25 companies on M&A activities and held sales position with Dover Medical Devices, J&J’s diagnostics equipment distributor in Israel at the time.
Mr. Blatt graduated as a biotechnology engineer from the Technion-Israel Institute of Technology in Haifa and holds an MBA from the Recanati School of Management at Tel Aviv University.